Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis
Article in Renal Failure (February 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Renal Failure (February 2024)
Article in Reactions Weekly (August 2023)
Article in Cureus (May 2023)